80 FR 38466 - Manufacturer of Controlled Substances Registration: Halo Pharmaceutical, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 128 (July 6, 2015)

Halo Pharmaceutical, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Halo Pharmaceutical, Inc. registration as a manufacturer of those controlled substances.

[Federal Register Volume 80, Number 128 (Monday, July 6, 2015)]
[Notices]
[Pages 38466-38467]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-16456]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Halo 
Pharmaceutical, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Halo Pharmaceutical, Inc. applied to be registered as a 
manufacturer of certain basic classes of controlled substances. The 
Drug Enforcement Administration (DEA) grants Halo Pharmaceutical, Inc. 
registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated January 9, 2015, and 
published in the Federal Register on January 26, 2015, 80 FR 3979, Halo 
Pharmaceutical, Inc., 30 North Jefferson Road, Whippany, New Jersey 
07981 applied to be registered as a manufacturer of certain basic 
classes of controlled substances. No comments or objections were 
submitted to this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Halo Pharmaceutical, Inc. to 
manufacture the basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Hydromorphone (9150).......................  II
------------------------------------------------------------------------

    The company plans to manufacture Hydromorphone HCL for sale to 
other manufacturers and to manufacture other controlled substances for 
distribution to its customers. Dihydromorphine is an intermediate in 
the manufacture of Hydromorphone and is not for commercial 
distribution.


[[Page 38467]]


    Dated: June 25, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-16456 Filed 7-2-15; 8:45 am]
 BILLING CODE 4410-09-P